Inovio reports inducement grants under inducement plan

Plymouth meeting, pa. , sept. 1, 2022 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from infectious diseases, cancer, and diseases associated with hpv, today announced that it has made equity grants to two newly hired employees, including a vice president of clinical development, under its 2022 inducement plan (the "inducement plan").
INO Ratings Summary
INO Quant Ranking